Autoinjector vs. syringe: which delivers sonelokimab better?
NCT ID NCT06994936
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study in 120 healthy adults compared two methods of giving a single dose of sonelokimab: a prefilled syringe and an autoinjector. The goal was to see if both methods deliver the same amount of drug into the body. Researchers measured drug levels in the blood and checked for side effects. The results will help decide if the autoinjector can be used in future studies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- sonelokimab
- What this could lead to
- If the autoinjector works as well as the syringe, patients may have a more convenient way to receive this medication.
- What could go wrong
- This is an early-phase study in healthy volunteers, not patients. It only checks drug levels, not whether the drug treats any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELATIVE BIOEQUIVALENCE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Site
London, United Kingdom